ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 1.53% of over the last 5 years
- The company is Net-Debt Free
2
With ROE of 8.53%, it has a Very Expensive valuation with a 0.15 Price to Book Value
- Over the past year, while the stock has generated a return of -12.23%, its profits have risen by 20.5% ; the PEG ratio of the company is 0.1
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -12.23% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
-12.23%
0.39
38.79%
Hang Seng Hong Kong
0.26%
0.01
20.12%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.82%
EBIT Growth (5y)
1.53%
EBIT to Interest (avg)
2.16
Debt to EBITDA (avg)
2.91
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.55
Tax Ratio
27.02%
Dividend Payout Ratio
32.58%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.01%
ROE (avg)
9.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.15
EV to EBIT
10.00
EV to EBITDA
4.11
EV to Capital Employed
0.38
EV to Sales
0.63
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
3.81%
ROE (Latest)
8.53%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 9,704.66 MM
ROCE(HY)
Highest at 6.99%
INTEREST COVERAGE RATIO(Q)
Highest at 557.62
NET PROFIT(Q)
Highest at HKD 1,961.99 MM
RAW MATERIAL COST(Y)
Fallen by -14.21% (YoY
NET SALES(Q)
Highest at HKD 24,164.48 MM
OPERATING PROFIT(Q)
Highest at HKD 3,739.52 MM
OPERATING PROFIT MARGIN(Q)
Highest at 15.48 %
EPS(Q)
Highest at HKD 0.69
-2What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 17,564.46 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.03 times
Here's what is working for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Operating Cash Flow
Highest at HKD 9,704.66 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Interest Coverage Ratio
Highest at 557.62
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Profit
Highest at HKD 1,961.99 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
Highest at HKD 24,164.48 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Profit
Highest at HKD 3,739.52 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 15.48 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
EPS
Highest at HKD 0.69
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Raw Material Cost
Fallen by -14.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 2,227.77 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 2,227.77 MM has Grown at 22.76%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Cash and Eqv
Lowest at HKD 17,564.46 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 4.03 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
